197 related articles for article (PubMed ID: 32468428)
1. Treatment Patterns of Lipid-Lowering Therapy in Patients with Coronary Artery Disease Aged Above and Below 75 Years: A Retrospective Cross-Sectional Study of 1500 Patients in a Tertiary Care Referral Center in Germany.
Dykun I; Wiefhoff D; Totzeck M; Al-Rashid F; Jánosi RA; Hendricks S; Rassaf T; Mahabadi AA
Drugs Aging; 2020 Jul; 37(7):521-527. PubMed ID: 32468428
[TBL] [Abstract][Full Text] [Related]
2. Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
Hong SJ; Lee YJ; Lee SJ; Hong BK; Kang WC; Lee JY; Lee JB; Yang TH; Yoon J; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK;
JAMA; 2023 Apr; 329(13):1078-1087. PubMed ID: 36877807
[TBL] [Abstract][Full Text] [Related]
3. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
[TBL] [Abstract][Full Text] [Related]
4. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction.
Tungsubutra W; Phongtuntakul B
J Med Assoc Thai; 2015 Feb; 98(2):129-36. PubMed ID: 25842792
[TBL] [Abstract][Full Text] [Related]
5. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
Pedersen TR; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Holme I; Larsen ML; Bendiksen FS; Lindahl C; Szarek M; Tsai J;
JAMA; 2005 Nov; 294(19):2437-45. PubMed ID: 16287954
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
7. Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease.
Kaasenbrood L; Ray KK; Boekholdt SM; Smulders YM; LaRosa JC; Kastelein JJP; van der Graaf Y; Dorresteijn JAN; Visseren FLJ
Heart; 2018 Oct; 104(20):1699-1705. PubMed ID: 29622600
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
[TBL] [Abstract][Full Text] [Related]
9. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
[TBL] [Abstract][Full Text] [Related]
10. Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol.
Lee SY; Oh SJ; Kim EJ; Oum CY; Park SH; Oh J; Kim JS; Kim BK; Park S; Chang HJ; Hong GR; Ko YG; Kang SM; Choi D; Ha JW; Hong MK; Jang Y; Chung N; Lee SH
PLoS One; 2016; 11(11):e0166246. PubMed ID: 27824924
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis--guidelines vs. reality.
Bożentowicz-Wikarek M; Kocełak P; Smertka M; Olszanecka-Glinianowicz M; Chudek J
Pharmacol Rep; 2012; 64(2):377-85. PubMed ID: 22661189
[TBL] [Abstract][Full Text] [Related]
12. High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention.
Kim J; Park KT; Jang MJ; Park TK; Lee JM; Yang JH; Song YB; Choi SH; Gwon HC; Lee SH; Hong KP; Hahn JY
J Am Heart Assoc; 2018 Nov; 7(21):e009517. PubMed ID: 30376751
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
14. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease.
Hilleman DE; Wurdeman RL; Lenz TL
Pharmacotherapy; 2001 Apr; 21(4):410-5. PubMed ID: 11310513
[TBL] [Abstract][Full Text] [Related]
16. Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials.
Kang S; Liu Y; Liu XB
Clin Ther; 2013 Aug; 35(8):1125-36. PubMed ID: 23932462
[TBL] [Abstract][Full Text] [Related]
17. Statin prescription strategies and atherogenic cholesterol goals attainment in Lebanese coronary artery disease patients.
Lama S; Souraya D; Youssef F
Int J Clin Pharm; 2017 Aug; 39(4):919-926. PubMed ID: 28523462
[TBL] [Abstract][Full Text] [Related]
18. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
19. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin.
Swindle JP; Potash J; Kulakodlu M; Kuznik A; Buikema A
Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005
[TBL] [Abstract][Full Text] [Related]
20. The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress.
Mulder DJ; van Haelst PL; Wobbes MH; Gans RO; Zijlstra F; May JF; Smit AJ; Tervaert JW; van Doormaal JJ
Cardiovasc Drugs Ther; 2007 Apr; 21(2):91-7. PubMed ID: 17342417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
